217 related articles for article (PubMed ID: 34032122)
21. Prognostic implications and procoagulant activity of phosphatidylserine exposure of blood cells and microparticles in patients with atrial fibrillation treated with pulmonary vein isolation.
Meng H; Kou J; Ma R; Ding W; Kou Y; Cao M; Dong Z; Bi Y; Thatte HS; Shi J
Mol Med Rep; 2017 Dec; 16(6):8579-8588. PubMed ID: 29039531
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
[TBL] [Abstract][Full Text] [Related]
23. Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers.
Pistrosch F; Matschke JB; Schipp D; Schipp B; Henkel E; Weigmann I; Sradnick J; Bornstein SR; Birkenfeld AL; Hanefeld M
Diabetologia; 2021 Dec; 64(12):2701-2712. PubMed ID: 34495376
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of circulating blood and endothelial cell microparticles in sickle-cell disease.
Kasar M; Boğa C; Yeral M; Asma S; Kozanoglu I; Ozdogu H
J Thromb Thrombolysis; 2014; 38(2):167-75. PubMed ID: 24254379
[TBL] [Abstract][Full Text] [Related]
25. Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head.
Kang P; Shen B; Yang J; Pei F
Thromb Res; 2008; 123(2):367-73. PubMed ID: 18495220
[TBL] [Abstract][Full Text] [Related]
26. Effects of transplanted circulating endothelial progenitor cells and platelet microparticles in atherosclerosis development.
Georgescu A; Alexandru N; Andrei E; Dragan E; Cochior D; Dias S
Biol Cell; 2016 Aug; 108(8):219-43. PubMed ID: 26968123
[TBL] [Abstract][Full Text] [Related]
27. Platelet function and microparticle levels in atrial fibrillation: Changes during the acute episode.
Pourtau L; Sellal JM; Lacroix R; Poncelet P; Bernus O; Clofent-Sanchez G; Hocini M; Haïssaguerre M; Dignat-George F; Sacher F; Nurden P
Int J Cardiol; 2017 Sep; 243():216-222. PubMed ID: 28747025
[TBL] [Abstract][Full Text] [Related]
28. Improved endothelial function and decreased levels of endothelium-derived microparticles after transcatheter aortic valve implantation.
Horn P; Stern D; Veulemans V; Heiss C; Zeus T; Merx MW; Kelm M; Westenfeld R
EuroIntervention; 2015 Apr; 10(12):1456-63. PubMed ID: 25287265
[TBL] [Abstract][Full Text] [Related]
29. An analysis of endothelial microparticles as a function of cell surface antibodies and centrifugation techniques.
Venable AS; Williams RR; Haviland DL; McFarlin BK
J Immunol Methods; 2014 Apr; 406():117-23. PubMed ID: 24603004
[TBL] [Abstract][Full Text] [Related]
30. Risks of Stroke and Mortality in Atrial Fibrillation Patients Treated With Rivaroxaban and Warfarin.
Alberts M; Chen YW; Lin JH; Kogan E; Twyman K; Milentijevic D
Stroke; 2020 Feb; 51(2):549-555. PubMed ID: 31888412
[TBL] [Abstract][Full Text] [Related]
31. Increased concentrations of platelet- and endothelial-derived microparticles in patients with myocardial infarction and reduced renal function- a descriptive study.
Mörtberg J; Lundwall K; Mobarrez F; Wallén H; Jacobson SH; Spaak J
BMC Nephrol; 2019 Mar; 20(1):71. PubMed ID: 30823870
[TBL] [Abstract][Full Text] [Related]
32. Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress.
Helal O; Defoort C; Robert S; Marin C; Lesavre N; Lopez-Miranda J; Risérus U; Basu S; Lovegrove J; McMonagle J; Roche HM; Dignat-George F; Lairon D
Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):665-71. PubMed ID: 20399083
[TBL] [Abstract][Full Text] [Related]
33. Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study.
Van Ganse E; Danchin N; Mahé I; Hanon O; Jacoud F; Nolin M; Dalon F; Lefevre C; Cotté FE; Gollety S; Falissard B; Belhassen M; Steg PG
Stroke; 2020 Jul; 51(7):2066-2075. PubMed ID: 32539675
[TBL] [Abstract][Full Text] [Related]
34. Positive Association between Endothelium-Platelet Microparticles and Urinary Concentration of Lead and Cadmium in Adolescents and Young Adults.
Lee CK; Wu C; Lin CY; Huang PC; Sung FC; Su TC
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578790
[TBL] [Abstract][Full Text] [Related]
35. Marathon running increases circulating endothelial- and thrombocyte-derived microparticles.
Schwarz V; Düsing P; Liman T; Werner C; Herm J; Bachelier K; Krüll M; Brechtel L; Jungehulsing GJ; Haverkamp W; Böhm M; Endres M; Haeusler KG; Laufs U
Eur J Prev Cardiol; 2018 Feb; 25(3):317-324. PubMed ID: 29183152
[TBL] [Abstract][Full Text] [Related]
36. Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension.
Diehl P; Aleker M; Helbing T; Sossong V; Germann M; Sorichter S; Bode C; Moser M
J Thromb Thrombolysis; 2011 Feb; 31(2):173-9. PubMed ID: 20680403
[TBL] [Abstract][Full Text] [Related]
37. Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia.
Trappenburg MC; van Schilfgaarde M; Marchetti M; Spronk HM; ten Cate H; Leyte A; Terpstra WE; Falanga A
Haematologica; 2009 Jul; 94(7):911-8. PubMed ID: 19508974
[TBL] [Abstract][Full Text] [Related]
38. Climacteric lowers plasma levels of platelet-derived microparticles: a pilot study in pre- versus postmenopausal women.
Rank A; Nieuwland R; Roesner S; Nikolajek K; Hiller E; Toth B
Acta Haematol; 2012; 128(1):53-9. PubMed ID: 22627113
[TBL] [Abstract][Full Text] [Related]
39. [Rivaroxaban at Non-Valvular Atrial Fibrillation: a Prospective Study and Clinical Practice].
Fonyakin AV
Kardiologiia; 2016 Aug; 56(8):87-92. PubMed ID: 28290887
[TBL] [Abstract][Full Text] [Related]
40. Endothelial cells microparticle-associated protein disulfide isomerase promotes platelet activation in metabolic syndrome.
Fan GQ; Qin RR; Li YH; Song DJ; Chen TS; Zhang W; Zhong M; Zhang Y; Xing YQ; Wang ZH
Oncotarget; 2016 Dec; 7(50):83231-83240. PubMed ID: 27825126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
